Detail akcie Haleon ADS-WI online

Business Summary: Haleon plc is a consumer healthcare company. The Company's product portfolio includes five categories, including oral health, vitamins, minerals, and supplements (VMS), pain relief, respiratory health, digestive health and others. The Company’s geographical segments include North America, Europe, Middle East, Africa, and Latin America (EMEA and LatAm, and Asia Pacific (APAC). Its respiratory health brands offer product solutions for a range of respiratory issues, including cold and flu, nasal congestion, coughs, and allergies. The Company's digestive health and other product offerings also include skin health and smoker’s health. Its oral health brands include Sensodyne, Polident, Parodontax, and Biotene. Its VMS brands include Centrum, Emergen-C, and Caltrate. Its respiratory brands include Otrivin, Theraflu, and Flonase. Its pain relief brands include Voltaren, Panadol, and Advil. Its digestive health brands include TUMS, ENO, and Fenistil.
Financial Summary: BRIEF: For the fiscal year ended 31 December 2024, Haleon PLC - ADR revenues decreased 1% to L11.23B. Net income increased 37% to L1.44B. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Net income reflects Disposals and others decrease from L32M (expense) to L131M (income), Separation and Admission Costs decrease of 75% to L29M (expense).